GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹192 Cr | ₹137 Cr | ₹122 Cr | ₹19 Cr | ₹23 Cr |
What is the latest Net Current Assets ratio of GENNEX LABORATORIES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹192 Cr |
| Mar2025 | ₹137 Cr |
| Mar2024 | ₹122 Cr |
| Mar2023 | ₹19 Cr |
| Mar2022 | ₹23 Cr |
How is Net Current Assets of GENNEX LABORATORIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹192 Cr | 40.77 | |
| Mar2025 | ₹137 Cr | 12.40 | |
| Mar2024 | ₹122 Cr | 533.85 | |
| Mar2023 | ₹19 Cr | -16.56 | |
| Mar2022 | ₹23 Cr | - | |
Compare Net Current Assets of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹199.4 Cr | -7.6% | -17.5% | -51% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -7.6% |
-17.5% |
-51% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses